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Background: Despite its high prevalence, most acute low back pain (ALBP) is nonspeciﬁ  c, 
self-limiting with no deﬁ  nable pathology. Recurrence is prevalent, as is resultant chronicity. 
Psychosocial factors (yellow ﬂ  ags comprising depression and anxiety, negative pain beliefs, 
job dissatisfaction) are associated with the development of chronic LBP.
Methods: A national insurer (Accident Compensation Corporation, New Zealand [NZ]), 
in conjunction with a NZ primary health organization, piloted a strategy for more effective 
management of patients with ALBP, by following the NZ ALBP Guideline. The guidelines 
recommend the use of a psychosocial screening instrument (Yellow Flags Screening Instrument, 
a derivative of Örebro Musculoskeletal Pain Questionnaire). This instrument was recommended 
for administration on the second visit to a general medical practitioner (GP). This paper tests 
whether published cut-points of yellow ﬂ  ag scores to predict LBP claims length and costs were 
valid in this cohort.
Results: Data was available for 902 claimants appropriately enrolled into the pilot. 25% 
claimants consulted the GP once only, and thus were not requested to provide a yellow ﬂ  ag 
score. Yellow ﬂ  ag scores were provided by 48% claimants who consumed two or more GP 
services. Approximately 60% LBP presentations resolved within ﬁ  ve GP visits. Yellow ﬂ  ag 
scores were signiﬁ  cantly and positively associated with treatment costs and service use, although 
the association was nonlinear. Claimants with moderate yellow ﬂ  ag scores were similarly likely 
to incur lengthy claims as claimants with at-risk scores.
Discussion: Capturing data on psychosocial factors for compensable patients with ALBP has 
merit in predicting lengthy claims. The validity of the published yellow ﬂ  ag cut-points requires 
further testing.
Keywords: acute low back pain, yellow ﬂ  ags, clinical guideline, lengthy claims
Background
Low back pain (LBP) is a signiﬁ  cant public health problem in the Western world, 
with as many as 84% of the general population believed to experience LBP at some 
point in their lives (Walker 2000). Despite its high prevalence, most LBP is typically 
nonspeciﬁ  c, with almost all events occurring in the absence of clearly deﬁ  nable 
pathology (NHMRC 2003). Whilst acute LBP is typically self-limiting, recurrence is 
prevalent and chronicity not uncommon (Bekkering et al 2003; NHMRC 2003). LBP 
impacts on the individual, and on workplaces, families and the wider community.
The New Zealand Accident Compensation Corporation (ACC) is a national 
compensable body. Its role, broadly speaking, is to provide insurance for all New 
Zealanders, injured in road accidents, at work, and in the community (ACC 2007). 
LBP places a substantial burden on health care resources, with such injuries costing 
ACC an estimated NZ$130 million per annum. Despite this spending, ACC claimant 
outcomes from LBP are not always satisfactory.
The use of clinical guidelines has been proposed as a way of improving health 
care processes and outcomes (Grimshaw et al 2004; Barosi 2006). Supporting an Journal of Pain Research 2008:1 16
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increasing consumer expectation of evidence-based health 
care, clinical guidelines are being produced for large numbers 
of conditions. LBP is no exception, with at least ten clinical 
practice guidelines currently in use around the world. 
Perceived beneﬁ  ts of the use of clinical guidelines include 
a reduction in inappropriate practice variations, increased 
clinical efﬁ  ciency and support, and better control of health 
care spending (Lenfant 2003; Grimshaw et al 2004). The 
research evidence is equivocal however, regarding the real 
cost and health outcomes of guideline-based care.
Recent advances in understanding of factors associated 
with LBP have recognised the inﬂ  uence of psychosocial 
factors on health outcomes, with current LBP guidelines 
reﬂ  ecting this (Kendall et al 1997; Bekkering et al 2003; 
NHMRC 2003; Holohan et al 2006). Psychosocial risk factors, 
including depression and anxiety, negative pain beliefs, low 
mood and job dissatisfaction, have strong associations with 
poor health outcomes and chronicity of LBP (Bekkering et al 
2003; NHMRC 2003; ACC 2004). Kendall (1999) proposes 
that many chronic pain behaviors are observable in the ﬁ  rst 
few days of incurring ALBP. However, few studies have 
investigated the efﬁ  cacy of strategies to prevent ALBP from 
developing into chronic pain (Newton-John et al 2001).
Most LBP clinical guidelines consistently advocate early 
identiﬁ  cation of LBP sufferers with at-risk psychosocial 
symptoms and behaviors, so that early targeted interventions 
can be put in place (Kendall et al 1997; Bekkering et al 
2003; NHMRC 2003; Holohan et al 2006). The Yellow Flags 
Screening Instrument (YFSI) (Kendall et al 1997) is an early 
version of the Örebro Musculoskeletal Pain Questionnaire 
(Linton and Boersma 2003). It is recommended as a 
mechanism to assess psychosocial factors associated with 
ALBP. Psychosocial factors include fear-avoidance behav-
ior, low mood/withdrawal, expectation of passive treatment 
and negative pain beliefs (Kendall et al 1997; Turk 1997; 
Linton and Hallden 1998; Kendall 1999; Linton and Boersma 
2003). The YFSI provides the following risk thresholds and 
descriptors (Kendall et al 1997, p 34–35):
• ‘Scores   105: “…will enable you to identify at least 
three-quarters of the long-term cases.”
•  Scores 90–105: “This group will include a proportion 
who are at risk for medium-term problems.”
• Scores    90: “Most of these patients will exhibit recovery 
within the expected time period.’
The YFSI is reported to identify ‘75% cases correctly 
of those not needing modiﬁ  cation to ongoing management, 
86% correct identiﬁ  cation of those who will have between 
1 and 30 days off work, and 83% correct identiﬁ  cation of 
those who will have more than 30 days off work’ (Kendall 
et al 1997, p 39). There is scant literature which validates 
these claims in other ALBP populations.
This paper reports on the validity of the Kendall et al 
(1997) yellow ﬂ  ag score cut-points to predict LBP claims 
length (and higher claims costs) for ACC ALBP claimants 
during 2006.
Methods
Ethics
Ethical approval for the study was provided by the University 
of South Australia Human Research Ethics Committee 
(Australia), New Zealand Health and Disability Northern 
Y Regional Ethics Committee, and an internal ACC Ethics 
Committee.
Setting
Auckland region, New Zealand.
Study background
ACC, in conjunction with a primary health organization 
(PHO), devised and piloted a strategy to facilitate more 
streamlined and effective management of patients with acute 
LBP, by following a ‘guidelines-based’ treatment protocol. 
PHOs are local structures for delivering and co-ordinating 
primary health care services. PHOs bring together doctors, 
nurses and other health professionals (such as Maori health 
workers, health promotion workers, dieticians, pharma-
cists, physiotherapists, psychologists and midwives) in the 
community to serve the needs of their enrolled populations. 
This pilot strategy was based on the New Zealand Acute 
LBP Guide (ACC 2004), a recommended clinical practice 
guideline (pathway) framed on a review of the relevant 
scientiﬁ  c literature within which the YFSI is embedded 
(Kendall et al 1997). It was envisaged that this pilot 
strategy would result in better claimant health outcomes, 
with corresponding cost beneﬁ  ts to ACC. The pathway 
recommended five general medical practitioner (GP) 
occasions of service in the episode of care for ALBP, and 
the application of the YFSI at the second visit. An episode 
of care is a set of congruent health care visits (occasions of 
service) for the management of the one condition (Grimmer 
et al 2000). If claimants had at-risk yellow ﬂ  ag scores, and/
or if their episode of care necessitated more than ﬁ  ve GP 
visits, then they should be referred to psychological services. 
A payment of over NZ$100 for the second visit was provided 
to GPs who assessed patients for yellow ﬂ  ags at the second 
visit, as per the ALBP protocol.Journal of Pain Research 2008:1 17
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Subjects
ACC claimants presenting to the GPs registered with the afﬁ  li-
ated GP organization between February and December 2006 
were eligible to be enrolled into the guidelines pilot program. 
The time period over which claimant data was analyzed was 
March–December 2006, which accounted for approximately 
98% of the enrolments into the pilot program. Approximately 
85% GPs in the PHO participated in the pilot program. The 
guidelines recommended up to ﬁ  ve visits to the participat-
ing GP as required, with the second visit being an extended 
consultation at which information on psychosocial factors 
(yellow ﬂ  ags) was recommended for capture, using a dedi-
cated IT decision-making tool, linked to the GP practice man-
agement system. Claimants whose ALBP was not resolving 
after the 2nd GP visit were eligible, under the treatment guide-
lines, to be referred to specialist pain management services 
(Physiotherapy, Psychology). Repeat yellow ﬂ  ag scores were 
captured as required, at subsequent visits during the episode 
of care, if the claimant’s symptoms were not resolving. Yellow 
ﬂ  ag assessment was however, not mandatory for claimants 
or GPs. Reasons for GPs not assessing claimants for yellow 
ﬂ  ags could be claimant refusal, GP disinterest, GP failure to 
follow the clinical pathway, or GP and claimant decision that 
sufﬁ  cient improvement in symptoms had occurred such that 
the claimant would require few further treatments (making 
yellow ﬂ  ag assessment unnecessary).
Red ﬂ  ags
Red ﬂ  ags are symptoms or history indicating immediate 
referral to a specialist. Red ﬂ  ags for acute LBP can include 
fractures, infection, symptoms of cancer, and psychiatric and 
neurological disturbances (NHMRC 2003). The ACC clinical 
pathway recommended that claimants with suspected red 
ﬂ  ags be referred immediately for treatment elsewhere.
Yellow ﬂ  ags
The published classiﬁ  cations of psychosocial risks (measured 
as yellow ﬂ  ags) were applied to the claimant cohort in this 
pilot program (Linton and Hallden 1998). However this 
data was not derived on a NZ-born population and therefore 
its utility had not been validated. Following the yellow 
ﬂ  ag risk thresholds and descriptors (Kendall et al 1997), 
claimants with yellow ﬂ  ag scores were classiﬁ  ed  105 
(high risk), between 90 and 105 (moderate to high risk) 
and 50–89 (moderate risk) (Kendall et al 1997; Linton and 
Hallden 1998). Claimants with scores lower than 50 were not 
considered to be at-risk of chronic pain behaviors, and thus 
were designated as the comparison group for all analysis.
Claims data
Claims were analyzed as number of services within the 
episode of care, and the length of time over which the episode 
of care (open claim) extended (claims length). The number 
of days lost from work was also examined. ACC legislation 
allows for lost earnings compensation to be paid after seven 
days off work. Therefore, absences of less than seven days 
from work are not present in the data. Thus it is not known 
how many claimants took no days off work, or less than 
seven days. The number of claimants in this data set who 
took more than seven days off work because of their ALBP 
is therefore not representative of claimants who took no, or 
less than seven, days off work.
Data analysis
Deidentified amalgamated data was provided on ACC 
claimant data for the period of the pilot program. The 
dataset included information on number and type of health 
service consultations per event of acute LBP (episode of 
care), demographic information (age, gender, self-reported 
ethnicity), claim duration and total cost, the number and type 
of health contacts, ‘red ﬂ  ag’ status and ‘yellow ﬂ  ag’ scores (if 
provided). Raw claims data was tabulated using MS Ofﬁ  ce 
Excel (Microsoft Corp., Redmond, WA, USA), and analysed 
using SAS Version 8.2 (SAS Inc., Cary, NC, USA).
The investigations reported in this paper considered only 
those claimants who consumed more than one GP visit. They 
were thus eligible to provide a yellow ﬂ  ag score on their 
second visit, as recommended in the guidelines. Gender, 
age and ethnicity characteristics, and claims length and 
cost, were described for those claimants who provided, or 
not, yellow ﬂ  ag scores using median (25th, 75th range) for 
the equal interval data, and percentages for the categorical 
data. Analysis of Variance models (for equal interval data) 
and chi square tests (for categorical data) were used to 
establish signiﬁ  cance (set at p   0.05 for all statistical tests). 
Signiﬁ  cant F and chi square values, and degrees of freedom 
(df    )  are  reported.
Within the subgroup of claimants which provided 
yellow ﬂ  ag scores, the characteristics of the different 
yellow ﬂ  ag classiﬁ  cations (outlined by Linton et al 1999) 
were investigated in a similar manner. Univariate logistic 
regression models using independent categories of yellow 
ﬂ  ag scores were used to identify whether the yellow ﬂ  ag 
score classiﬁ  cations linearly predicted claims outcomes 
and costs. The comparison group was claimants with 
yellow ﬂ  ag scores 0–49 (considered to have low risk of 
chronicity). Signiﬁ  cant odds ratios were identiﬁ  ed when the Journal of Pain Research 2008:1 18
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95% conﬁ  dence intervals (CIs) did not encompass 1. The 
confounding effect of ethnic status, gender and age on 
this association was then investigated using step-wise 
multivariate logistic regression models. The confound-
ing effect in the multivariate regression models was 
assessed during construction of the stepwise models by 
the signiﬁ  cance of the amount of change in the Likelihood 
Ratio (df, p value).
Hypotheses underpinning testing
There is a positive linear relationship between yellow ﬂ  ag 
scores, claims length, and claims costs.
Results
Claimants
Figure 1 outlines the consort diagram for the pilot program, 
in which 902 eligible claimants were appropriately enrolled 
into this pilot program, 223 claimants consulted a GP once 
only and thus did not enter the clinical pathway, and of the 
remainder, 328 provided yellow ﬂ  ag scores.
Median age of the 902 eligible claimants was 38 years 
(25th% to 75th% 30–46 years) (range 16–72 years), with 
males predominating (58.8%). There was no signiﬁ  cant 
gender difference in mean age. These claimants self-
reported ethnicity, comprising European (42.8%), Asian 
(12.8%), Maori (12.2%), Middle Eastern/Latin American/
African 1.4%, Paciﬁ  c Islanders 18.7% and other (Indian, 
etc) (12.1%). The demographic proﬁ  le of the ACC cohort 
did not differ from that of the greater Auckland city area, 
North Shore City, or Manukau City (Statistics New Zealand 
2002), suggesting generalizable ﬁ  ndings to other LBP 
sufferers.
Diagnosis was assigned by the treating GP using ACC 
codes. The predominant diagnosis was lumbar sprain (73.3%), 
followed by lumbar spine pain (7.8%), other (undeﬁ  ned) 
(7%), thoracic sprain (3.9%), lumbar disc prolapse with 
radiculopathy (3.1%), sacroiliac ligament sprain (2.2%), 
sciatica (1.8%), back sprain (0.6%), and lumbosacral strain 
(0.3%). There was no data available of inter-or intra-rater 
GP reliability when assigning these diagnostic codes, or the 
appropriateness of the diagnostic codes.
Claims information
The eligible claimants (N = 902) consumed 5976 health 
services during the pilot program (median 3 services per 
claimant, range 1–74) (25th% to 75th% 2–9). Claimants 
could not enter the ACC clinical pathway without an initial 
GP visit, which was the only contact for 223 claimants 
(24.7% total) (that is, they required no further treatment 
of any kind and thus did not proceed down the clinical 
path). These claimants were excluded from the analysis 
reported in this paper. A range of services were con-
sumed by the remaining claimants (those recording two 
or more visits to health providers), namely physiotherapy 
(44.6%), GP (35%), acupuncture (8%), chiropractics 
(4.6%), diagnostic radiology (2.2%), osteopathy (1.9%), 
medical specialties (3.6%). Overall, this cohort cost ACC 
$275,783.54 (median cost $148.09 per claimant for an 
episode of care for acute LBP) (25th%–75th% $49.60 
to $366.02).
Yellow ﬂ  ag scores
For the remaining claimants (N = 679), the clinical pathway 
recommended assessing psychosocial risk using the YFSI 
on the second GP visit. Yellow ﬂ  ags data was available 
for 328 claimants (48.8%) who consumed two or more GP 
(See Figure 1).
Considering the claimant cohort which attended the GP 
for two visits or more, there was no signiﬁ  cant difference 
between claimants who provided yellow ﬂ  ag scores and 
those who did not (in age, gender proportions, diagnostic 
categories, occasions of service, length of episode of 
care, or the percentage of claimants who took more than 
seven days off work (and the number of days they took off 
work)). Occasions of service reﬂ  ected any health service 
consumption, not just general medical practitioners. There 
was a signiﬁ  cant difference in unadjusted claims costs 
however, between the two groups, with the yellow ﬂ  ag 
claimant group having high median costs which reﬂ  ected 
the increased payment for assessing yellow ﬂ  ag scores on an 
extended second visit consultation. When this  payment was 
removed from the total claims costs for this group, the dif-
ference between groups was no longer signiﬁ  cant (adjusted 
median total cost for the yellow ﬂ  ag group $155.14 (25th% 
$78.40, 75th% $386.30). The comparison data is provided 
in Table 1.
To add weight to the similarity in service delivery 
consumption patterns (and adjusted total costs) of the 
claimants who provided, or not, yellow ﬂ  ag scores within 
this cohort, similar distribution of the numbers of occa-
sions of service in the claimants’ episodes of care for their 
ALBP is provided in Figure 1. Thus the ﬁ  ndings from 
the claimants who consumed two or more GP visits and 
provided yellow ﬂ  ag scores are generalizable to those who 
also consumed two or more GP visits, but did not provide 
yellow ﬂ  ag scores.Journal of Pain Research 2008:1 19
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Claimants with yellow ﬂ  ag scores
Claimant yellow ﬂ  ag scores ranged from 10 to 146. Of 
the claimants who provided yellow ﬂ  ag scores, N = 67 
(20%) had scores less than 49 (deemed to be low risk of 
developing chronic LBP). N = 175 (52.9%) had yellow ﬂ  ag 
scores between 50–89 (some risk of chronic LBP, whilst 
N = 45 (13.6%) had scores between 90 and 105 (moderate 
to high risk of chronic LBP. Forty-four claimants (13.3%) 
had at-risk scores  105. This indicated, using the scoring 
criteria, that over 73% of the claimants who provided yellow 
ﬂ  ag scores had no, or minimal, risk of developing persistent 
pain behaviors.
Demographic and service consumption 
differences in yellow ﬂ  ag claimant groups
Demographic characteristics of the claimants with yellow 
ﬂ  ags are reported in Table 2. There was no need to adjust 
the cost of claims in this yellow ﬂ  ags subset as all GPs 
had the opportunity receive the extended visit payment for 
collecting yellow ﬂ  ag scores on the second visit. There was 
no signiﬁ  cant difference in the frequency of gender, common 
diagnostic condition (lumbar sprain) and the number of days 
off work greater than seven, across the yellow ﬂ  ag groups. 
There was a signiﬁ  cant difference across the groups in the 
frequency of ethnicity (chi square 35.6 18df      ) p   0.05, as 
well as signiﬁ  cant differences (all with 3df) in the median 
length of claims (F = 11.5), the number of occasions of 
service in the episode of care (F = 8.54), and total claims 
costs (F = 8.9) (  p   0.05). Occasions of service reﬂ  ected 
any health service consumption, not just general medical 
practitioner visits. There was also a signiﬁ  cant difference in 
the percentage of claimants in each yellow ﬂ  ag category who 
took more than seven days off work (F = 7.8) ( p   0.05).
Ethnic differences
The significant influence of ethnicity on psychosocial 
factors is evidenced by the distribution of yellow flag 
scores (Figure 2) in which the score distribution of the 
Middle Eastern/Latin American/African group scores was 
signiﬁ  cantly higher than the 75th% of the other ethnic groups. 
Differences in service costs are illustrated in Figure 3 by 
the signiﬁ  cantly higher distribution of scores for the Asian 
claimants compared with all others.
Treatment costs
Compared to claimants with yellow ﬂ  ag score less than 50 
(not at-risk of chronic pain behaviors), all other claimants 
with yellow ﬂ  ag scores were signiﬁ  cantly more likely to 
incur treatment costs in excess of the overall median cost 
per claimant (NZ$148.09). Signiﬁ  cance was indicated as the 
95% CI did not encompass 1 for any of the associations. For 
the low risk of LBP chronicity (yellow ﬂ  ag scores of 50–89, 
the unadjusted odds of incurring claims costs in excess of 
$148.09 was 6.8 (95% CI 4.5–10.3). For the moderate risk 
Table 1 Demographic proﬁ  le of claimants consuming two or more GP visits, and providing, or not, yellow ﬂ  ag scores
Claimants not providing 
yellow ﬂ  ag scores
Claimants providing yellow 
ﬂ  ag scores
Age (Median 25th%, 75th%) [range] 38 (30–46) [18–85] 39 (31–47) [18–75]
Claims length (Median 25th%, 75th%) [range] 27 (9–105) [3–312] 19 (10–66.5) [1–389]
Occasions of service (Median 25th%, 75th%) [range] 5 (2–10) [2–56] 6.5 (2–11.5) [2–74]
Days off work  7 (Median 25th%, 75th%) [range] Incurred by 6.3% 22 
(10–105) [4–312]
Incurred by 10.1% 27 (8–64) 
[1–389]
Total unadjusted cost of claim (Median 5th%, 75th%)
[range]
$154.04
($77.33–$385.19) 
[$48.89–$3838.24]
$265.78
($148.09–$541.55) 
[$58.32–$5476.81)]
Gender 57.3% Male 55.6% Male
Most common diagnosis Lumbar sprain (71.2%) Lumbar sprain (77.6%)
Ethnicity
• European 37.8% 51.3%
• Asian 15.1% 8.8%
• Maori 13.2% 10.3%
• Paciﬁ  c Islander 19.3% 17.8%
• Middle Eastern/Latin American/African 1.6% 1.2%
• Other 13.0% 10.6%
Note: Signiﬁ  cant differences identiﬁ  ed by bold text.Journal of Pain Research 2008:1 21
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Table 2 Characteristics of claimants in yellow ﬂ  ag groups
Low yellow ﬂ  ag 
scores 0–49
Moderate yellow ﬂ  ag 
scores 50–89
Moderate to High yel-
low ﬂ  ag scores 90–105
At-risk yellow ﬂ  ag 
cores  105
Age (median, 25th%, 75th%) 40 (29–47) [18–69] 38.5 (31–47) [18–75] 39.5 (31.5–48.0) [20–57] 37 (31–46) [19–73]
Claims length (median, 
25th%, 75th%) [range]
12.0 (7–30) [0–254] 32 (10–86) [2–498] 46 (17.5–78.5) [4–370] 71 (23–238) [3–396]
Days off work  7 
(% yellow ﬂ  ag group) Median 
(25th%, 75th%), range
1.5% 4 (4–4), [4] 12.6% 27 (14-60) [7-287] 20% 12 (5-20) [3-339] 27.3% 49.5 (32.5-214.5) 
[1–389]
Occasions of service (median, 
25th%, 75th%), [range]
3 (2–7) [2–37] 6 (2–12) [1–44] 8 (3–11) [1–46] 9.5 (5–16.5) [2–74]
Total cost of claim (median, 
25th%, 75th%)
$148.09
($100.33–$325.26) 
[$58.32–$1433.16]
$258.85
($148.09–$541.55) 
[$58.32–$3974.10]
$350.52
($148.09–$485.29) 
[$58.32–$5421.28]
$740.75
($265.65–$1560.38) 
[$58.32–$5476.81]
Gender (Male) 55.2% 51.8% 61.4% 65.1%
Most common diagnosis Lumbar sprain (77.6%) Lumbar sprain (70.6%) Lumbar sprain (79.6%) Lumbar sprain (69.9%)
Ethnicity
• Asian 14.9% 7.1% 6.8% 6.9%
• European 40.3% 56.5% 50.0% 48.8%
• Maori 4.5% 12.4% 11.4% 11.6%
• Paciﬁ  c Islander 0.0% 0.0% 2.3% 6.9%
•   Middle Eastern/Latin 
American/African
14.9% 14.1% 25.0% 13.9%
• Other 23.9% 10.0% 4.6% 12.5%
Note: Signiﬁ  cant differences identiﬁ  ed by bold text.
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of LBP chronicity group (yellow ﬂ  ags scores 90–105), the 
unadjusted odds was 15.6 (95% CI 5.5–44.1), and for the high 
risk of LBP chronicity group (yellow ﬂ  ag score  105), the 
unadjusted odds was 11.9 (95% CI 4.6–30.5). This supports 
the general hypothesis that the higher yellow ﬂ  ag scores, the 
greater the likelihood of higher treatment costs.
Chronicity reflected by long claims: Considering 
claimants with yellow ﬂ  ag scores, and considering the median 
overall claims length (11 days), compared to claimants with 
low yellow ﬂ  ag scores (less than 50), ‘high-risk’ claimants 
(yellow ﬂ  ag scores  105) were signiﬁ  cantly (seven times) 
more likely to have a claim lasting greater than the median 
claims length (unadjusted odds ratio [95%CI] 7.1 [2.7–19.1]). 
Claimants with yellow ﬂ  ag scores between 50–89 were also 
signiﬁ  cantly more likely to become chronic (unadjusted 
odds ratio (95%CI) 2.5 (1.1–5.9), however claimants scoring 
between 90–105 did not have a signiﬁ  cantly elevated risk 
compared with the not-at-risk claimants (unadjusted odds 
ratio (95%CI) 1.9 (0.6–5.5).
Adjusting for confounding
Significant change in the likelihood ratio (LR) in the 
stepwise multivariate logistic regression models indicated 
that ethnicity was a signiﬁ  cant confounder on the association 
between yellow ﬂ  ags classiﬁ  cations and total cost (LR 20.2, 
8df, p   0.05) and yellow ﬂ  ags classiﬁ  cations and claims 
length (LR 12.3, 8df, p   0.05). The addition of gender or 
age did not signiﬁ  cantly increase the LRs (LR 3.1, 9df; LR 
1.9, 9df, respectively). The adjusted odds of claimants in the 
different yellow ﬂ  ags categories incurring costs higher than 
$148.09 or claims lasting longer than 11 days is reported in 
Table 2. The probability that higher yellow ﬂ  ag scores will 
predict high cost and claims length was increased in all yellow 
ﬂ  ag score categories, compared with the low risk category. 
There was similar risk of high cost claims occurring in the 
moderate, and moderate to high categories (in the range of 
2–3 times the risk), with strongly elevated probability (nearly 
8 times the risk) in the at-high risk group. Comparing the 
unadjusted and adjusted odds ratios for high cost, it appears 
that the confounding effect of ethnicity was greatest in the 
moderate to high risk yellow ﬂ  ag score category, as thus 
group showed the greatest change between unadjusted and 
adjusted odds. There was a different and linearly increasing 
risk pattern across the categories for long claims length, 
ranging from OR of three in the moderate risk group, six 
in the moderate to high risk group, and nine in the at-risk 
group). The moderate to high risk group again showed the 
greatest effect of deconfounding.
Claims lasting 90 days or more
The yellow ﬂ  ags classiﬁ  cations claim to be able to predict 
claimants who will have extended claims. ACC deﬁ  nes 
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extended claims as those lasting greater than three months 
( 90 days). Overall, of all claimants in the ACC pilot 
cohort (N = 902), 138 (15.3%) had claims which were not 
closed within 90 days. Sixty-three of this subset of claimants 
(45.7%) did not have a recorded yellow ﬂ  ag score, indicating 
that their care had not complied with the ACC clinical 
pathway.
Confounding by ethnicity but not by gender or age 
was the same for this analysis, as indicated by the change 
in LRs at each step (LRs 19.6 8df, 3.8 9df, 3.9 9df, 
respectively). Considering the adjusted odds ratios from 
the step wise regression models, there were signiﬁ  cant and 
elevated probabilities that moderate, and at-risk yellow 
ﬂ  ag classiﬁ  cations would predict claims lasting longer 
than 90 days, compared to low risk yellow ﬂ  ag scores. 
However, despite deconfounding by ethnicity, the risk of 
claims  90 days in the moderate to high risk yellow ﬂ  ag 
group was no different to the low risk group, as outlined 
in Table 3. These ﬁ  ndings suggest that the classiﬁ  cations 
of yellow ﬂ  ag scores require revising to more accurately 
predict lengthy claims.
To consider the sensitivity and speciﬁ  city of the proposed 
yellow ﬂ  ag score classiﬁ  cations in this cohort of ALBP 
claimants, the number of claimants in the four yellow ﬂ  ag 
score categories with respect to extended (90 + days) claims 
length is presented in Table 4. The YFSI performed best when 
identifying claimants with low yellow ﬂ  ag scores who would 
not become chronic cases (speciﬁ  city of 84.6%). Sensitivity 
was poorer (26.7%), as only 20 of the 75 claimants with a 
claim lasting in excess of 90 days, had yellow ﬂ  ag scores 
greater 105, and were correctly identiﬁ  ed as at high-risk 
for chronicity. Of the 44 claimants who had at-risk yellow 
ﬂ  ag scores ( 105), less than half became chronic cases. 
Conversely just over one-fifth of low to moderate risk 
claimants (scores 50–89), and just under one-ﬁ  fth of mod-
erate to high risk claimants (scores 89–105) had extended 
claims, which refutes the notion that high yellow ﬂ  ag scores 
are sensitive predictors of lengthy claims. Considering 
claimants with yellow ﬂ  ag scores of 90+, only 45.6% were 
correctly identiﬁ  ed as consuming claims longer than 90 days, 
which is considerably lower than the predicted percentage 
(89%) (Linton and Boersma 2003).
Referral
Less than a third (31.8%) of claimants deemed at ‘high-risk’ 
due to their yellow ﬂ  ag score were referred to psychological 
services, as recommended in the clinical pathway. 
Furthermore, of those who were referred, claimant utilization 
of these services was poor, with only three claimants 
completing treatment. Given the constraints on the data 
provided by ACC for this paper, it could not be determined 
why this low referral or completion rate occurred.
Discussion
This paper reports on a rare opportunity to examine 
psychosocial risk related to cost and claims length, in a large 
northern-New Zealand cohort of compensable claimants 
with ALBP. Claimant demography is representative of 
the wider northern New Zealand population. The clinical 
pathway underpinning the management of claimants with 
ALBP provided ﬁ  nancial incentives for GPs to collect yellow 
ﬂ  ag scores from claimants who attended twice or more. Of 
the ACC claimants who had this opportunity to provide 
yellow ﬂ  ags scores, the characteristics of the claimants who 
provided yellow ﬂ  ag scores were no different from those 
who did not provide yellow ﬂ  ag scores. We believe that 
this sample is generalizable to other compensable claimants 
with ALBP.
Data limitations
Of those claimants who attended their GP at least twice and 
thus were eligible to provide a yellow ﬂ  ag score, less than 
half did so. This raises questions about yellow ﬂ  ag scores 
for the noncompliant subset. In health services research 
which evaluates processes and outcomes of service delivery 
programs applied in ‘everyday’ settings, it is not possible 
to predict how individual practitioners and claimants will 
behave, despite them agreeing to comply with established 
Table 3 Adjusted odds of high costs and high claims length occurring in yellow ﬂ  ag groups, compared with the lowest risk group (AOR, 
95% CI)
Lowest risk 
yellow ﬂ  ags  50
Moderate risk 
yellow ﬂ  ags 50–89
Moderate to high risk 
yellow ﬂ  ags 90–105
At-risk 
yellow ﬂ  ags  105
Costs   $148.09 1 (comparison) 2.2 (1.2–4.1) 3.3 (1.4–8.1) 7.6 (2.6–21.7)
Claims lasting   11 days 1 (comparison) 2.8 (1.5–5.1) 6.2 (2.3–16.4) 9.4 (3.0–29.0)
Claims lasting   90 days 1 (comparison) 3.4 (1.3–8.9) 2.6 (0.8–8.3) 12.1 (4.0–36.2)
Note: Signiﬁ  cant associations highlighted in bold.Journal of Pain Research 2008:1 24
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Table 4 Distribution of claimants by yellow ﬂ  ag scores and claim 
length
Yellow ﬂ  ag score
 50 50–89 90–105  105
Claims  90 days 60 132 37 24
Claims  90 days 74 08 2 0
% all claims  90 days 9.3% 53.3% 10.7% 26.7%
program protocols. On reﬂ  ection, at least 100 claimants 
who did not provide a yellow ﬂ  ag score can potentially 
be accounted for. Figure 1 reported that approximately 
25% of the claimants who consumed two visits or more, 
and provided no yellow ﬂ  ag scores, only consumed two 
occasions of service within their episode of care. Furthermore 
approximately 10% only consumed three occasions of service 
in their episode of care. It is possible that, if the patient and 
GP predicted the imminent closure of the ALBP episode 
of care, they may have legitimately decided not to record a 
yellow ﬂ  ag score. This could be veriﬁ  ed by the nonpayment 
of the second visit payment to these claimants’ GPs. If this 
assumption is correct, the percentage of eligible yellow ﬂ  ag 
claimants who did not provide yellow ﬂ  ag scores, and, could 
be reduced to approximately 30% for whom no reasonable 
explanation could be found other than noncompliance.
There is little rationale in the ALBP clinical guidelines 
(ACC 2004) for collecting yellow ﬂ  ag scores on the second 
GP visit. While chronic pain behaviors are believed to be 
exhibited early in an episode of ALBP, it is not known 
whether capture of information on psychosocial risk at the 
ﬁ  rst, second or subsequent visits to the GP is appropriate. 
Despite the increased second visit payment for assessing 
yellow ﬂ  ag scores. GPs may not have been sufﬁ  ciently 
motivated or conﬁ  dent to capture this information from their 
patients, particularly if these practice behaviors were foreign 
to them. Further information needs to be obtained from GPs 
and their patients regarding their perspectives on the use of 
a standard protocol for the management of ALBP.
Crawford and colleagues (2007) suggests that for 
many GPs, identiﬁ  cation and management of psychosocial 
factors depends on their world-view and orientation to the 
biopsychosocial model of pain. This may be reﬂ  ected in 
the infrequent GP use of the YFSI in the management of 
patients with ALBP, despite the payment. Many GPs report 
treating patients purely according to biomedical principles 
initially, until a lack of progress was evident (Crawford et al 
2007). Thus administering the YFSI on the second GP visit 
(as stipulated in the ACC clinical pathway) may not have 
coincided with GPs’ beliefs or usual management practices. 
It may also not have been acceptable to claimants. In the 
same vein, referral of claimants with high yellow ﬂ  ag scores 
to psychological services may not have coincided with GPs 
or patients’ beliefs, which may have accounted for the low 
psychological counselling referral and treatment completion 
rate. These issues need to be better understood, as compliance 
by clinician and patient with any agreed clinical protocol is 
essential to its effectiveness (Grimshaw et al 2004).
Yellow ﬂ  ag scores
Yellow ﬂ  ag scores were signiﬁ  cantly confounded by ethnicity 
but not gender or age. Claimants of middle Eastern ethnic 
background had signiﬁ  cantly higher yellow ﬂ  ags than any 
other racial group. Considering the overall group median 
scores, increasing yellow ﬂ  ag scores were generally linearly 
related to higher claims costs and claims length. This concurs 
with the claims of the YFSI developers that the higher 
the yellow ﬂ  ag score, the more likely it is to predict long 
claims.
Claims longer than 90 days
When predicting claims lasting longer than 90 days however, 
despite deconfounding for ethnicity, claimants with scores 
between 50–89 (who traditionally represent a low to moderate 
risk (Linton and Hallden 1998; ACC 2004)), recorded 
a stronger probability of incurring a lengthy claim than 
claimants scoring 90–105. This ﬁ  nding challenges the notion 
that claimants with scores less than 90 are considered together 
as posing similarly and low level of risk for poor outcomes 
(Linton and Hallden 1998; ACC 2004).
The sensitivity of the YFSI high-risk classiﬁ  cation was 
poor (less than 30%) and thus it needs to be reconsidered for 
use in this NZ cohort of ALBP claimants. Given the wide 
score range available for ‘low-risk’ claimants (50 points), 
in comparison to the available range of low to moderate 
risk (39 points) and moderate to high risk (15 points), it 
is perhaps not surprising that different risk proﬁ  les exist 
within each classiﬁ  cation, particularly given the different 
ethnic proﬁ  les in each yellow ﬂ  ag score classiﬁ  cation. The 
intention for the YFSI is to assist in identifying claimants to 
whom appropriate allocation of additional resources would 
be beneﬁ  cial (Linton and Hallden 1998). From these results, 
there appears to be a considerable proportion of claimants 
who are being overlooked. Claimants previously deemed 
at low or moderate risk may still beneﬁ  t from referral to 
other services, such as counseling. Further investigation of 
yellow ﬂ  ag score classiﬁ  cations with respect to ethnicity, Journal of Pain Research 2008:1 25
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and increased claims cost, lengthy claims and development 
of chronic pain is warranted.
Conclusion
For those individuals whose ALBP threatens to take longer 
to resolve, there appears to be merit in embedding an assess-
ment of psychosocial factors within a clinical pathway. This 
claim is supported by the generally linear association between 
yellow ﬂ  ag scores, treatment costs and claims length. How-
ever the YFSI requires testing in other ALBP populations 
to improve the sensitivity of its high score classiﬁ  cations 
in detecting individuals who are likely to have extended 
claims length (for instance greater than 90 days). Although 
the speciﬁ  city of the YFSI was high, the high percentage of 
claimants who scored low on the YFSI yet consumed lengthy 
claims requires investigation with respect to yellow ﬂ  ag score 
range, and ethnicity.
Approximately 60% ALBP presentations in this sample 
resolved within ﬁ  ve GP visits (as anticipated by the ACC 
clinical pathway). This describes the natural progression 
of, and expected compensable costs related to, ALBP. The 
standard ALBP protocol of applying the YFSI at the second 
GP visit needs to be revisited in light of the number of 
claimants who did not comply. These potentially included 
those who ceased care after the second or third GP visit, those 
claimants whose psychosocial risks were assessed as high, but 
did not consume lengthy episodes of care, and those claimants 
whose risks were assessed as low, and who had long claims.
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